A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.

Autor: Scesney, Susanne M., Makrides, Savvas C., Gosselin, Michael L., Ford, Pamella J., Andrews, Beth M., Hayman, Edward G., Marsh, Henry C.
Zdroj: European Journal of Immunology; Aug1996, Vol. 26 Issue 8, p1729-1735, 7p
Databáze: Complementary Index